Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02885558Completed
Randomised trial of Efonidipine in endothelial dysfunction (2 arms), sponsored by University of Southern Denmark. Primary endpoint: Vascular function at 8 weeks. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02885558.